Medical College of Wisconsin
CTSI
Research Informatics
REDCap
Faculty Collaboration Database
Profiles for MCW, MU, MSOE, UWM, BCW, CW, Froedtert, and VA Faculty
Email:
Pass:
Lost Password? / First Time Login Help
Home
About
Search
Contact
Tips
Tutorials
Browse MESH
Kevin R. Rogacki MD
Assistant Professor
Institution:
Medical College of Wisconsin
Department:
Radiation Oncology
Member of the
Cancer Center
Send Message
Request Meeting
View Curriculum Vitae
Publications (8)
Clinical, Pathologic, and Dosimetric Predictors of Head and Neck Lymphedema Following Definitive or Adjuvant Radiation Therapy for Head and Neck Cancer.
(Rogacki KR, Teo PT, Gopalakrishnan M, Pachigolla SL, Lyons CE, Abazeed ME, Das I, Mittal BB, Gentile M)
Adv Radiat Oncol
2024 Sep;9(9):101545 PMID: 39184143 PMCID: PMC11343725 SCOPUS ID: 2-s2.0-85200164174 08/26/2024
9 Citations
Determining risk and predictors of head and neck cancer treatment-related lymphedema: A clinicopathologic and dosimetric data mining approach using interpretable machine learning and ensemble feature selection
(Teo PT, Rogacki K, Gopalakrishnan M, Das IJ, Abazeed ME, Mittal BB, Gentile M)
Clinical and Translational Radiation Oncology
May 2024;46 SCOPUS ID: 2-s2.0-85186517568 05/01/2024
18 Citations
Multivalent state transitions shape the intratumoral composition of small cell lung carcinoma.
(Gopal P, Petty A, Rogacki K, Bera T, Bareja R, Peacock CD, Abazeed ME)
Sci Adv
2022 Dec 14;8(50):eabp8674 PMID: 36516249 PMCID: PMC9750150 SCOPUS ID: 2-s2.0-85144198406 12/15/2022
17 Citations
Investigation of brachial plexus dose that exceeds RTOG constraints for apical lung tumors treated with four- or five-fraction stereotactic body radiation therapy
(Manyam BV, Verdecchia K, Rogacki K, Reddy CA, Zhuang T, Videtic GMM, Azok J, Stephans K)
Journal of Radiosurgery and Sbrt
2019;6(3):189-197 SCOPUS ID: 2-s2.0-85071452242 01/01/2019
9 Citations
Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review.
(Murphy ES, Rogacki K, Godley A, Qi P, Reddy CA, Ahluwalia MS, Peereboom DM, Stevens GH, Yu JS, Kotecha R, Suh JH, Chao ST)
Pract Radiat Oncol
2017;7(6):e391-e399 PMID: 28666902 SCOPUS ID: 2-s2.0-85021780843 07/02/2017
16 Citations
Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy.
(Li Z, Alyamani M, Li J, Rogacki K, Abazeed M, Upadhyay SK, Balk SP, Taplin ME, Auchus RJ, Sharifi N)
Nature
2016 May 26;533(7604):547-51 PMID: 27225130 PMCID: PMC5111629 SCOPUS ID: 2-s2.0-84971273444 05/27/2016
157 Citations
A genetic basis for the variation in the vulnerability of cancer to DNA damage.
(Yard BD, Adams DJ, Chie EK, Tamayo P, Battaglia JS, Gopal P, Rogacki K, Pearson BE, Phillips J, Raymond DP, Pennell NA, Almeida F, Cheah JH, Clemons PA, Shamji A, Peacock CD, Schreiber SL, Hammerman PS, Abazeed ME)
Nat Commun
2016 Apr 25;7:11428 PMID: 27109210 PMCID: PMC4848553 SCOPUS ID: 2-s2.0-84964659853 04/26/2016
146 Citations
Integrative analysis of the zinc finger transcription factor Lame duck in the Drosophila myogenic gene regulatory network.
(Busser BW, Huang D, Rogacki KR, Lane EA, Shokri L, Ni T, Gamble CE, Gisselbrecht SS, Zhu J, Bulyk ML, Ovcharenko I, Michelson AM)
Proc Natl Acad Sci U S A
2012 Dec 11;109(50):20768-73 PMID: 23184988 PMCID: PMC3528522 SCOPUS ID: 2-s2.0-84874416769 11/28/2012
20 Citations
Last update: 06/24/2026